Sacheerome FY26: Margin expansion at over 120% utilization, with YEIDA plant as the next growth lever
Ask Iris
/** Note: MDX-ready Markdown blogpost text. */
Sacheerome FY26: Margin expansion at over 120% utilization, with YEIDA plant as the next growth lever
Sacheerome Limited closed FY26 with a sharp step-up in scale and profitability. Revenue from operations rose to INR152.39 crores (from INR107.54 crores in FY25), while EBITDA increased to INR40.66 crores and PAT to INR28.44 crores. Profitability expanded alongside growth, with EBITDA margin improving to 26.02% (from 21.61% in FY25) and PAT margin rising to 18.20%.
Management attributed the margin improvement largely to operating leverage. FY26 growth was delivered from the existing facility, without a proportionate rise in costs, as the company operated at capacity utilization above 120% (management indicated around 124%). This combination of strong demand and capacity constraints sets the context for the company’s next phase: commissioning a new manufacturing facility in YEIDA, Uttar Pradesh.
Business mix: fragrances dominate, flavours remain small but positioned to scale
The company operates in two business segments: fragrances and flavours. FY26 continued to be dominated by the fragrance business, while flavours remained a smaller contributor.
On the geography mix, Sacheerome remains primarily domestic. In FY26, domestic sales contributed 93.81% of revenue from operations and exports 6.19%. While the export share dipped versus FY25 (7.63%), management stated exports increased in absolute terms, with exports rising from approximately INR8 crores in FY25 to approximately INR9.5 crores in FY26.
H2 FY26: growth with improving margins
For H2 FY26, total income was INR78.06 crores versus INR57.58 crores in H2 FY25, a YoY increase of 35.57%. EBITDA grew faster than revenue, reaching INR19.56 crores (up 48.77%), and PAT rose to INR13.50 crores (up 51.19%). The company also showed a meaningful improvement in H2 margins, with EBITDA margin at 25.06% and PAT margin at 17.30%.
Financial snapshot (INR crores)
Capacity constraint and the YEIDA expansion: the central strategic lever
The most important operational disclosure from the earnings call was the company’s current utilization level. Management stated that the existing plant was operating above 120% utilization, approximately 124%. In that backdrop, the YEIDA project is positioned as a scale enabler.
Management described the YEIDA facility as more than a capacity expansion. They highlighted expected benefits across automation, manufacturing efficiency, product consistency, export capabilities, and scalability. The facility is planned to include R&D, Quality, Application, and Consumer Evaluation Centers.
Key project disclosures from management include:
- Total YEIDA project capex: about INR184 crores
- Investment into YEIDA facility up to 31 March 2026: about INR76.59 crores
- Funding split of invested amount: IPO funds INR28.79 crores; internal accruals INR47.80 crores
- Expected start of commercial operations: August 2026 (management also said they will try to start in July)
Management acknowledged delays in the timeline due to vendor-side issues, including manpower constraints and material availability, and also mentioned a delay in local stainless steel fabrication parts. However, they stated civil work is complete and the plant has arrived.
Guidance: topline targets through FY29, focus on sustaining operating margins
A key takeaway from the concall is that the company provided explicit revenue guidance for the next three years:
- FY26-27 revenue guidance: INR200 crores
- FY27-28 revenue guidance: INR250 crores
- FY28-29 revenue guidance: INR300 crores
On margins, management indicated the operating margin for FY25-26 was approximately 25% and stated they will aim to perform at the same level despite higher depreciation and geopolitical conditions. During Q&A, management clarified that operating margins referred to EBIT margins at approximately 25%.
The company also discussed capex funding and indicated that around INR60 crores of debt could be used for the facility, to be utilized as and when required.
What changed in FY26: customer additions and operating leverage
The CFO provided a clear breakdown of what drove revenue growth. Revenue from operations increased by INR44.85 crores in FY26, of which INR13.61 crores came from new customers and INR31.24 crores from existing customers. This helps validate that growth is not dependent on a single lever.
Management also stated that the increase in operating margin was supported by cost growth being limited relative to topline expansion, implying fixed-cost absorption.
R&D-led positioning and industry tailwinds
Sacheerome positions itself as a creative house for fragrances and flavours. The company highlights a sizeable R&D team and stated in the concall that R&D spend is around 2.3% of sales. Management also described the business as customer-brief driven, where product development is customized to demography, geography, gender, age group, income group, and trends.
In the investor presentation, the company also pointed to broader industry tailwinds, including growth in FMCG and demand across personal care, home care, food and beverage, and hygiene categories.
Closing takeaways
FY26 stands out for two reasons: first, strong growth combined with margin expansion; second, evidence that the existing facility is capacity constrained, which makes the upcoming YEIDA commissioning central to the next phase.
The near-term watch items are execution and ramp-up of the new plant, the impact of higher depreciation on reported profitability, and how quickly the company can translate additional capacity into sustained growth. With clear topline guidance through FY28-29 and a stated goal of sustaining operating margins around FY26 levels, the next few quarters will likely be judged on commissioning discipline and early utilization traction.
Frequently Asked Questions
Did your stocks survive the war?
See what broke. See what stood.
Live Q1 Earnings Tracker
